Literature DB >> 18665072

Changing incidence of pancreatic neoplasms: a 16-year review of statewide tumor registry.

Timothy L Fitzgerald1, Zach J Hickner, Matthew Schmitz, Eric J Kort.   

Abstract

OBJECTIVES: Although most pancreatic neoplasms are adenocarcinoma, there are many other histological types, some of which may be increasing in frequency. To better define these trends, we reviewed 16 years of data from a statewide tumor registry.
METHODS: Using the State of Michigan tumor registry, all patients with primary pancreatic cancers from 1986 to 2002 were identified, and patients were excluded if there were insufficient data or the histological subtype was not clearly defined in the literature.
RESULTS: There were 17,610 pancreatic neoplasms identified, and 2425 were excluded, leaving a final population of 15,185. Twenty-five types of primary pancreatic neoplasms were identified. The most common were adenocarcinoma, mucinous cystadenocarcinoma, nonfunctional neuroendocrine, adenosquamous, anaplastic, intraductal papillary mucinous, and acinar cell (8.37, 0.43, 0.18, 0.05, 0.04, 0.04, and 0.02 per 100,000 per year, respectively). The mean age at presentation was similar for tumor types, 69.2 years old, with the exception of endocrine neoplasms occurring at a younger age, 58.5 years old (P < 0.0005). There was a significant change in the incidence of nonfunctional neuroendocrine neoplasms, greater than 2-fold increase (P = 0.0003).
CONCLUSIONS: The incidence of most pancreatic neoplasms has changed a little; however, nonfunctional neuroendocrine neoplasms increased greater than 2-fold. The etiology of this change is unclear.

Entities:  

Mesh:

Year:  2008        PMID: 18665072     DOI: 10.1097/MPA.0b013e318163a329

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  47 in total

1.  Pancreatic neuroendocrine tumours: hypoenhancement on arterial phase computed tomography predicts biological aggressiveness.

Authors:  David J Worhunsky; Geoffrey W Krampitz; Peter D Poullos; Brendan C Visser; Pamela L Kunz; George A Fisher; Jeffrey A Norton; George A Poultsides
Journal:  HPB (Oxford)       Date:  2013-08-29       Impact factor: 3.647

2.  415 patients with adenosquamous carcinoma of the pancreas: a population-based analysis of prognosis and survival.

Authors:  Casey A Boyd; Jaime Benarroch-Gampel; Kristin M Sheffield; Catherine D Cooksley; Taylor S Riall
Journal:  J Surg Res       Date:  2011-07-07       Impact factor: 2.192

Review 3.  [Pancreatic ductal adenocarcinoma].

Authors:  E Gallmeier; T M Gress
Journal:  Internist (Berl)       Date:  2018-08       Impact factor: 0.743

4.  Tumor registry versus physician medical record review: a direct comparison of patients with pancreatic neuroendocrine tumors.

Authors:  Elisabet E Manasanch; Jillian K Smith; Andreea Bodnari; Jeannine McKinney; Catherine Gray; Theodore P McDade; Jennifer F Tseng
Journal:  J Oncol Pract       Date:  2011-03       Impact factor: 3.840

Review 5.  [Branch duct intraductal papillary mucinous neoplasm - surgical approach].

Authors:  J Kaiser; M W Büchler; T Hackert
Journal:  Chirurg       Date:  2017-11       Impact factor: 0.955

6.  Implications of incidentally discovered, nonfunctioning pancreatic endocrine tumors: short-term and long-term patient outcomes.

Authors:  Alex B Haynes; Vikram Deshpande; Thun Ingkakul; Parsia A Vagefi; Jackie Szymonifka; Sarah P Thayer; Cristina R Ferrone; Jennifer A Wargo; Andrew L Warshaw; Carlos Fernández-del Castillo
Journal:  Arch Surg       Date:  2011-05

Review 7.  Pathology and Surgical Treatment of High-Grade Pancreatic Neuroendocrine Carcinoma: an Evolving Landscape.

Authors:  Sven-Petter Haugvik; Daniel Kaemmerer; Sebastien Gaujoux; Knut Jørgen Labori; Caroline Sophie Verbeke; Ivar Prydz Gladhaug
Journal:  Curr Oncol Rep       Date:  2016-05       Impact factor: 5.075

8.  Pancreatic fistulae after pancreatic resections for neuroendocrine tumours compared with resections for other lesions.

Authors:  Jasper Jan Atema; Anneke P J Jilesen; Olivier R C Busch; Thomas M van Gulik; Dirk J Gouma; Els J M Nieveen van Dijkum
Journal:  HPB (Oxford)       Date:  2014-07-18       Impact factor: 3.647

Review 9.  Adenosquamous carcinoma of the pancreas: Molecular characterization of 23 patients along with a literature review.

Authors:  Erkut Borazanci; Sherri Z Millis; Ron Korn; Haiyong Han; Clifford J Whatcott; Zoran Gatalica; Michael T Barrett; Derek Cridebring; Daniel D Von Hoff
Journal:  World J Gastrointest Oncol       Date:  2015-09-15

10.  Grading of EUS-FNA cytologic specimens from patients with pancreatic neuroendocrine neoplasms: it is time move to tissue core biopsy?

Authors:  Rakesh Vinayek; Gabriele Capurso; Alberto Larghi
Journal:  Gland Surg       Date:  2014-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.